Skip to main content

WALGREENS

  • Retail pharmacy focuses support on Gulf Coast region

    HOUSTON — One week following Hurricane Harvey, the Gulf region where that powerful storm made landfall is beginning to put the pieces back together. For example, Walmart, among other retailers have reported the reopening of all stores with the exception of a handful of locations impacted by flooding.

  • J.D. Power pharmacy rankings take downturn on negative Rx price perception

    COSTA MESA, Calif. — The U.S. pharmacy industry, perennially one of the highest-scoring industries measured by J.D. Power, experienced notable declines in overall customer satisfaction this year, the research firm reported Tuesday. According to the J.D. Power 2017 U.S. Pharmacy Study, decreases in satisfaction with both brick-and-mortar and mail order pharmacies were driven primarily by declines in satisfaction with cost.

  • Daymon: Wearables of the future may be ideal shopper touchpoints for retailers

    STAMFORD, Conn. — Could fitness trackers and apps connect retailers to consumers in a whole new way? Daymon, a team of private label merchandising and marketing consultants, seem to think so.

    The Daymon team tested a few products to find out, as evidenced by the infographic below, including the Walgreens Striiv activity tracker and the Higi app.

  • Retail pharmacy community continues immense show of support in wake of Harvey

    ARLINGTON, Va. — In response to Hurricane Harvey (now Tropical Storm Harvey), which has brought devastating flooding to southeastern Texas, chain and associate member companies of the National Association of Chain Drug Stores have mobilized in collaboration with public health partners and emergency preparedness authorities to meet the ongoing needs of people in Texas affected by the storm.

    Retail pharmacy operators have responded to the emergency with everything from donations and supplies to generators and mobile food trucks.

  • Antitrust suit involving generic Lipitor, Effexor XR back on

    A United States appeals court has revived an antitrust lawsuit against four drug makers, alleging that they hamstrung generics for Lipitor and Effexor XR.

    The plaintiffs, a coalition of labor unions and retailers, including Rite Aid and Walgreens, accused four drug makers of reverse settlement payment deals, in which a drug’s patent holder pays the accused infringer not to produce the patented item. The plaintiffs allege Ranbaxy accepted such payments from Pfizer to delay generics for Lipitor, while Wyeth accepted payments from Teva to delay Effexor XR.

  • Walgreens Boots Alliance intros CYO Cosmetics

    NEW YORK — Walgreens Boots Alliance today has launched CYO, an exclusive makeup line designed for younger customers, featuring 160 items that can be mixed and matched.

    The CYO portfolio includes eye shadows that can be used wet or dry for different effects, highlighting creams that can be mixed or layered for shimmer and an assortment of blushers. All items in the collection range in price from $3.50 to $7.50.

  • Retail pharmacy responds to communities in south Texas

    AUSTIN, Texas — In response to the devastation associated with Hurricane Harvey, several retailers have stepped up their giving.

  • CVS, Walgreens and Walmart each ace Disability Equality Index

    WASHINGTON — CVS Health, Walgreens and Walmart each received a perfect score of 100% on the 2017 Disability Equality Index, a national benchmarking survey and report on corporate policies and practices related to disability inclusion and workplace equality, administered by the U.S. Business Leadership Network and American Association of People with Disabilities.

X
This ad will auto-close in 10 seconds